Local News: Mims, FL 

 | 

Sign Up

 | 

Sign In

Advertisment

ICON Wire

Comprehensive News Feed for ICON.

Results 1 - 20 of 41 in ICON

  1. Updates-ICONRead the original story

    Yesterday | American Chronicle

    ... A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 12/17/09, ICON Plc (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device ...

    Comment?

    Related Topix: Biotech, Healthcare Law, Law, Food and Drug Administration, Science / Technology, Medicine, ImmunoGen, Healthcare Industry, Opinion

  2. Dr. John Climax Announces His Retirement as Chairman of ICON plc -...Read the original story

    Thursday Dec 17 | BusinessWire

    ICON Plc , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that Dr.

    Comment?

    Related Topix: Biotech, Outsourcing

  3. ICON plc UK Regulatory Announcement: Dr. John Climax Announces His...Read the original story

    Thursday Dec 17 | Business Wire

    Dr. John Climax announces his retirement as Chairman of ICON plc - Dr. Bruce Given elected to succeed him Dublin, Ireland, December 17th, 2009 - ICON Plc , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that Dr.

    Comment?

    Related Topix: Biotech, Ireland, Dublin, Ireland, World News, Leinster, Ireland, Outsourcing

  4. ICON Central Laboratories Expands its European FacilityRead the original story

    Tuesday Dec 15 | Applied Clinical Trials

    ICON plc has expanded its European Central Laboratory, located in South County Business Park, Dublin.

    Comment?

    Related Topix: Biotech

  5. ICON Expands Central Lab in EuropeRead the original story

    Monday Dec 14 | Contract Pharma Breaking News

    ICON has expanded its European Central Laboratory, located in South County Business Park, Dublin.

    Comment?

    Related Topix: Biotech

  6. ICON Central Laboratories Expands its European Facility to Meet Growing DemandRead the original story

    Monday Dec 14 | BusinessWire

    ICON plc, , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has expanded its European Central Laboratory, located in South County Business Park, Dublin.

    Comment?

    Related Topix: Biotech, Outsourcing

  7. "Spectacular timing" by ICON directors - the luck of the Irish?Read the original story

    Sunday Dec 13 | PharmaGossip

    ICON Plc founders Ronan Lambe and John Climax , as well as chief executive Peter Gray , were blessed with spectacular timing as they sold close to 10m worth of shares in the firm shortly before its shares tanked after a "warning" from the US Food and Drug Administration .

    Comment?

    Related Topix: Biotech, Food and Drug Administration

  8. Icon bosses sell 10m shares before US 'warning'

    Saturday Dec 12 | Kildare Nationalist

    ICON Plc founders Ronan Lambe and John Climax , as well as chief executive Peter Gray , were blessed with spectacular timing as they sold close to 10m worth of shares in the firm shortly before its shares tanked after a "warning" from the US Food and Drug Administration .

    Comment?

    Related Topix: Biotech, Food and Drug Administration

  9. ICON Announces Details of New Translational Medicine Unit in ManchesterRead the original story

    Monday Dec 7 | BusinessWire

    ICON plc, , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced details of its new translational medicine unit in Manchester, UK.

    Comment?

    Related Topix: Biotech, Outsourcing, Central Manchester, CT

  10. ICON Receives Warning Letter Relating to Two Studies

    Friday Dec 4 | Drugs.com

    Dec 4, 2009 - ICON plc, , today announced it has received a warning letter from the U.S. Food and Drug Administration regarding clinical study management services provided by the company to one of its clients in relation to two studies conducted between 2004 and 2006.

    Comment?

    Related Topix: Biotech, Food and Drug Administration

  11. ICON receives FDA warning letterRead the original story

    Friday Dec 4 | Medical News

    ICON plc, , today announced it has received a warning letter from the U.S. Food and Drug Administration regarding clinical study management services provided by the company to one of its clients in relation to two studies conducted between 2004 and 2006.

    Comment?

    Related Topix: Food and Drug Administration, Biotech, Health

  12. ICON plc UK Regulatory Announcement: ICON Receives Warning Letter Relating to Two StudiesRead the original story

    Friday Dec 4 | BusinessWire

    ICON plc, , today announced it has received a warning letter from the U.S. Food and Drug Administration regarding clinical study management services provided by the company to one of its clients in relation to two studies conducted between 2004 and 2006.

    Comment?

    Related Topix: Biotech, Food and Drug Administration

  13. Monday's Rx-RecapRead the original story

    Nov 3, 2009 | The Biotech Stock Blog

    ... patients with decompensated cirrhosis, in which BARACLUDE demonstrated greater viral suppression compared to adefovir. ICON plc, (NASDAQ: ICLR ) , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical ...

    Comment?

    Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Outsourcing, Eli Lilly, Auxilium Pharmaceuticals, Oncology

  14. Updates for Bristol-Myers

    Nov 3, 2009 | American Chronicle

    ... decompensated cirrhosis, in which BARACLUDE demonstrated greater viral suppression compared to adefovir. On 11/02/09, ICON plc, (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical ...

    Comment?

    Related Topix: Biotech, Bristol Myers Squibb, Medicine, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Outsourcing, Science / Technology, Opinion

  15. ICON, Lilly Extend Data Management Pact To JapanRead the original story

    Nov 2, 2009 | Contract Pharma Breaking News

    ICON has signed an extension to its strategic agreement with Lilly to manage the company's clinical data outside the U.S. ICON will now also oversee Lilly's needs in Japan in addition to those in Europe, Canada, Latin America, Australia and Asia.

    Comment?

    Related Topix: Biotech

  16. Eli Lilly selects ICON to provide clinical data management outside the USRead the original story

    Nov 2, 2009 | Medical News

    ICON plc, , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed an extension to its strategic agreement with Eli Lilly and Company to manage the companya s clinical data management outside the US.

    Comment?

    Related Topix: Biotech, Eli Lilly, Medicine, Healthcare Industry, Outsourcing, Health

  17. ICON Selected by Lilly to Oversee its Clinical Data Management in JapanRead the original story

    Nov 1, 2009 | Business Wire

    ICON plc, , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed an extension to its strategic agreement with Eli Lilly and Company to manage the company's clinical data management outside the US.

    Comment?

    Related Topix: Biotech, Outsourcing, Eli Lilly, Medicine, Healthcare Industry

  18. a a a 3a 3a a a 1 4a a a aa aa 1 4a Sa OEae- aeoe a a OEa 'a e aoOEa a 1 4a a c c a 'a -e -Read the original story

    Nov 1, 2009 | Business Wire

    ICON/ICLR-G Sharing Permalink Permalink To save a permanent link to this news, right-click and choose the command to copy the link, link location or shortcut.

    Comment?

    Related Topix: Biotech

  19. Pharma Researchers Need a CureRead the original story

    Oct 29, 2009 | The Motley Fool

    ... reports followed quarterly results announced earlier this week by two other prominent CROs -- Covance (NYSE: CVD ) and Icon (Nasdaq: ICLR ) , which offered mixed results. Strategic responses CROs can't stop the revenue-rattling impact of Pfizer 's ...

    Comment?

    Related Topix: Biotech, Medicine, Healthcare Industry, Pharmaceutical Product Development, Covance, Pfizer, Schering Plough

  20. Taking the Drug Industry's TemperatureRead the original story

    Oct 23, 2009 | The Motley Fool

    ... industry, research and development, can bese be measured by the health of companies such as Covance (NYSE: CVD ) and Icon (Nasdaq: ICLR ) . These contract research organizations, or CROs, conduct anything from pre-clinical tests to late-stage ...

    Comment?

    Related Topix: Biotech, Merck , Medicine, Healthcare Industry, Schering Plough, Covance